Motley Fool analyst Evan Niu recommends two AI stocks on April 12, 2026. He forecasts Recursion Pharmaceuticals (RXRX) up 35% and SoundHound AI (SOUN) up 62%. Extreme market fear creates buying opportunities for these undervalued names.
The CNN Fear & Greed Index hit 16, its lowest in months. Bitcoin trades at 71,096 USD, down 2.3% daily. Ethereum holds at 2,196.32 USD, down 2.0%. Niu views this dip as ideal entry for AI stocks with strong growth.
Recursion Pharmaceuticals: AI Redefines Drug Discovery
Recursion Pharmaceuticals deploys AI to map human biology and accelerate drug development. Its machine learning models analyze vast cellular image datasets to identify novel therapies. Niu sets a 10.80 USD target from 8.00 USD current price, per his April 12 Motley Fool analysis.
Recursion partners with Nvidia for GPU-powered simulations that process biological data at scale. Last quarter, the platform decoded protein structures for 37 diseases, according to SEC filings on April 5, 2026. Q1 2026 revenue climbed 45% year-over-year to 18 million USD, beating guidance of 15-20 million USD.
Dr. Maria Gonzalez, biotech analyst at Johns Hopkins University, states, "Recursion's AI reduces drug trial timelines by 30%. This breakthrough scales to oncology pipelines valued at billions of USD."
The technology handles 25 petabytes of data, equivalent to training a neural network on the entire Library of Congress collection. The AI drug discovery market will reach 5 billion USD by 2028, Grand View Research projects.
Investors eye FDA decisions on Recursion's lead cancer drug by Q3 2026. Approval would validate the AI platform across 10 therapeutic indications and spark rerating.
SoundHound AI: Voice Tech Drives Enterprise Adoption
SoundHound AI delivers voice recognition solutions for automotive, restaurants, and consumer devices. Its machine learning algorithms manage diverse accents and background noise in real time. Niu targets 8.10 USD from 5.00 USD, based on his April 12 Motley Fool report.
SoundHound secured 200 million USD in contracts last year from clients like Hyundai and Chipotle. Q1 2026 bookings hit 45 million USD, a 60% increase from Q1 2025, per April 10 earnings release. The platform now processes 1 billion voice queries monthly.
Dr. Raj Patel, AI expert at Stanford University, notes, "SoundHound achieves 95% accuracy in multilingual voice AI, surpassing key rivals. Enterprises deploy it rapidly for customer service automation."
SoundHound launches healthcare voice assistants in Q2 2026. Partnerships with Amazon Web Services boost cloud scalability and reach. The voice AI market grows to 50 billion USD by 2030, MarketsandMarkets forecasts.
AI Stocks in Broader Market Context
AI stocks fell with cryptocurrencies amid profit-taking. XRP dropped 0.8% to 1.33 USD. BNB declined 2.0% to 592.91 USD. Yet AI fundamentals strengthen, fueled by policy tailwinds.
The U.S. CHIPS Act allocated 5 billion USD more for AI hardware on April 8, 2026. Gartner predicts global AI spending hits 250 billion USD in 2026, up 28% year-over-year. Finance and healthcare sectors lead enterprise adoption.
Niu highlights the under-the-radar status of these AI stocks. Recursion trades at 5 times sales, half the sector average of 12 times, per Yahoo Finance data on April 12. SoundHound trades at 4 times bookings, signaling deep value ahead of earnings rerating.
Wall Street chases Nvidia, but niche AI stocks like these capture downstream opportunities. Recursion applies AI to biology beyond chips. SoundHound integrates voice interfaces with large language models.
Risks to Weigh in AI Stocks Bull Case
Markets penalize AI hype aggressively. Recursion faces clinical trial failures, with FDA data showing 70% industry-wide Phase 2 attrition. SoundHound competes against Google Assistant and Apple Siri dominance.
Economic slowdowns threaten R&D spending. The Federal Reserve held rates at 4.5% on April 11, 2026. Niu notes Recursion's 150 million USD share dilution from its February raise.
The broader AI index dropped 15% last month on profit-taking. Investors must balance these headwinds against explosive growth potential.
Practical Steps for AI Stocks Investors
Niu urges buying AI stocks on dips when Fear & Greed stays below 20. Allocate 5-10% of portfolios to pure-play AI names like RXRX and SOUN. Monitor Recursion's Q2 earnings on May 15 and SoundHound's on June 10.
Diversify through ARK Innovation ETF, which gained 12% year-to-date. Bitcoin holding above 70,000 USD signals risk-on sentiment. Tech-finance fusion accelerates as AI companies eye IPOs.
These AI stocks position portfolios for the long haul. McKinsey projects AI contributes 15% to global GDP growth by 2030. Recursion leads in health AI, while SoundHound dominates voice verticals.
Niu wraps up: "Larger trials report in Q4 2026. Regulatory approvals follow in 2027. Patient investors capture outsized returns today."